View Study [5]"Efficacy and safety of CagriSema in type 2 diabetes" Frias JP et al., 2023 Finding: In people with type 2 diabetes, CagriSema achieved 15.6% weight loss versus 5.1% with semaglutide alone over 32 weeks, with comparable HbA1c reductions and good tolerability
GLP-1 RA Head-to-Head Trials In summary, these head-to-head clinical trials between GLP-1RA and DPP-4 inhibitors showed that the difference between the drugs lies in the ability of the GLP-1RA to consistently improve glycemic control and decrease weight ( Switch Trials A small number of clinical trials have evaluated switching patients from a DPP-4 inhibitor (sitagliptin) to a GLP-1RA
Quality & Testing Independently tested by accredited third-party laboratories
Pathophysiology of MD MD represents a distinct neuropathological entity characterized by the confluence of both AD and VaD pathologies, resulting in a clinical syndrome with accelerated progression and unique mechanistic interactions
f Plan data based on number of pharmacy lives as reported by Managed Markets Insight & Technology, LLC (current as of August 2023)
Finally, while we maintain our concern regarding the overall utility of the MEMS pressure sensor, we agree with the applicant that the LithoVue TM Elite Ureteroscope, inclusive of the MEMS pressure sensor, meets the criterion because the MEMS pressure sensor is not a detachable or an adjunctive component to the ureteroscope itself, which we previously agreed is necessary and/or required to furnish or deliver the primary procedure (ureteroscopy) with which it is used